| Dr Ali Jamshidi, MD | |
|
410 W 10th Ave, N1014 Doan Hall, Columbus, OH 43210-1240 | |
| (614) 293-0821 | |
| (614) 293-4281 |
| Full Name | Dr Ali Jamshidi |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 14 Years |
| Location | 410 W 10th Ave, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558651539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 57017940 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Woodland Hills | Woodland hills, CA | Hospital |
| Kaiser Foundation Hospital - Los Angeles | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Teaching middle-school children about nutrition and exercise and encouraging them to watch less TV can save the health care system a substantial amount of money, suggests an economic analysis from Children's Hospital Boston and the Centers for Disease Control and Prevention.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that a cross of 1,480,000 common shares has been effected through Canaccord Capital Inc. at a sales price of $0.05 per common share.
Despite the millions of dollars that have been invested into research to improve methods of treatments for various types of cancer, oncological diseases continue to have a high mortality rate, remaining one of the main causes of death globally. Traditional cancer treatment methods, such as chemotherapy, immunotherapy, and radiotherapy are effective in approximately only half of all patients.
The risk of developing cervical cancer can be significantly decreased through human papillomavirus vaccination. Despite calls from leading health and professional organizations for universal vaccination for girls ages 11 and 12, the most recently published national data indicate that only 14.5 percent of 11- and 12-year-old girls have received at least one dose of the HPV vaccine and 3 percent have completed the three-dose series. A new Moffitt Cancer Center study provides insight into physician recommendations, one important factor that may contribute to these low levels of uptake.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
› Verified 2 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Teaching middle-school children about nutrition and exercise and encouraging them to watch less TV can save the health care system a substantial amount of money, suggests an economic analysis from Children's Hospital Boston and the Centers for Disease Control and Prevention.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that a cross of 1,480,000 common shares has been effected through Canaccord Capital Inc. at a sales price of $0.05 per common share.
Despite the millions of dollars that have been invested into research to improve methods of treatments for various types of cancer, oncological diseases continue to have a high mortality rate, remaining one of the main causes of death globally. Traditional cancer treatment methods, such as chemotherapy, immunotherapy, and radiotherapy are effective in approximately only half of all patients.
The risk of developing cervical cancer can be significantly decreased through human papillomavirus vaccination. Despite calls from leading health and professional organizations for universal vaccination for girls ages 11 and 12, the most recently published national data indicate that only 14.5 percent of 11- and 12-year-old girls have received at least one dose of the HPV vaccine and 3 percent have completed the three-dose series. A new Moffitt Cancer Center study provides insight into physician recommendations, one important factor that may contribute to these low levels of uptake.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
› Verified 2 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659329746 PECOS PAC ID: 4082510250 Enrollment ID: O20031209000514 |
News Archive
Teaching middle-school children about nutrition and exercise and encouraging them to watch less TV can save the health care system a substantial amount of money, suggests an economic analysis from Children's Hospital Boston and the Centers for Disease Control and Prevention.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that a cross of 1,480,000 common shares has been effected through Canaccord Capital Inc. at a sales price of $0.05 per common share.
Despite the millions of dollars that have been invested into research to improve methods of treatments for various types of cancer, oncological diseases continue to have a high mortality rate, remaining one of the main causes of death globally. Traditional cancer treatment methods, such as chemotherapy, immunotherapy, and radiotherapy are effective in approximately only half of all patients.
The risk of developing cervical cancer can be significantly decreased through human papillomavirus vaccination. Despite calls from leading health and professional organizations for universal vaccination for girls ages 11 and 12, the most recently published national data indicate that only 14.5 percent of 11- and 12-year-old girls have received at least one dose of the HPV vaccine and 3 percent have completed the three-dose series. A new Moffitt Cancer Center study provides insight into physician recommendations, one important factor that may contribute to these low levels of uptake.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ali Jamshidi, MD 410 W 10th Ave, N1014 Doan Hall, Columbus, OH 43210-1240 Ph: () - | Dr Ali Jamshidi, MD 410 W 10th Ave, N1014 Doan Hall, Columbus, OH 43210-1240 Ph: (614) 293-0821 |
News Archive
Teaching middle-school children about nutrition and exercise and encouraging them to watch less TV can save the health care system a substantial amount of money, suggests an economic analysis from Children's Hospital Boston and the Centers for Disease Control and Prevention.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today announced that a cross of 1,480,000 common shares has been effected through Canaccord Capital Inc. at a sales price of $0.05 per common share.
Despite the millions of dollars that have been invested into research to improve methods of treatments for various types of cancer, oncological diseases continue to have a high mortality rate, remaining one of the main causes of death globally. Traditional cancer treatment methods, such as chemotherapy, immunotherapy, and radiotherapy are effective in approximately only half of all patients.
The risk of developing cervical cancer can be significantly decreased through human papillomavirus vaccination. Despite calls from leading health and professional organizations for universal vaccination for girls ages 11 and 12, the most recently published national data indicate that only 14.5 percent of 11- and 12-year-old girls have received at least one dose of the HPV vaccine and 3 percent have completed the three-dose series. A new Moffitt Cancer Center study provides insight into physician recommendations, one important factor that may contribute to these low levels of uptake.
Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the initiation of the QUANTUM-R Phase 3 clinical trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3 (FLT3)-ITD mutation.
› Verified 2 days ago
Dr. Mynor Mendez Valdez, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 300 W 10th Ave Fl 12, Columbus, OH 43210 Phone: 440-975-6868 | |
Douglas A. Hardesty, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave, Columbus, OH 43210 Phone: 614-293-8714 Fax: 614-293-4281 | |
Michael J Meagher, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 931 Chatham Ln, Columbus, OH 43221 Phone: 614-533-5500 Fax: 614-533-5593 | |
Sigurdur A Stephensen, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 931 Chatham Ln, Columbus, OH 43221 Phone: 614-457-4880 Fax: 614-457-4890 | |
Dr. Vikram Badhri Chakravarthy, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 300 W 10th Ave, Columbus, OH 43210 Phone: 614-293-8714 Fax: 614-293-4281 | |
Dr. Andrew James Grossbach, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 543 Taylor Ave, Columbus, OH 43203 Phone: 614-293-8714 Fax: 614-293-4281 | |
Dr. Gregory W. Balturshot, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3525 Olentangy River Rd, Suite 5310, Columbus, OH 43214 Phone: 614-261-0073 Fax: 614-268-5611 |